{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:42:17Z","timestamp":1790502137842,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jvs.2020.10.075","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T12:29:12Z","timestamp":1606393752000},"page":"1802-1810.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease"],"prefix":"10.1016","volume":"73","author":[{"given":"Sherwin","family":"Abdoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2020.10.075_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jcin.2016.06.008","article-title":"Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials","volume":"9","author":"Giacoppo","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.10.075_bib2","first-page":"CD006767","article-title":"Angioplasty versus bare metal stenting for superficial femoral artery lesions","volume":"6","author":"Chowdhury","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2020.10.075_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/1526602815607187","article-title":"Occluded superficial femoral and popliteal artery stents can have a negative impact on bypass target","volume":"22","author":"Conway","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.10.075_bib4","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.10.075_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries","volume":"71","author":"Mohapatra","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.10.075_bib6","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2019"},{"key":"10.1016\/j.jvs.2020.10.075_bib7","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2020.10.075_bib8","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS med"},{"key":"10.1016\/j.jvs.2020.10.075_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1538574411422276","article-title":"Comparison of embolic load in femoropopliteal interventions: percutaneous transluminal angioplasty versus stenting","volume":"46","author":"Brancaccio","year":"2012","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.10.075_bib10","first-page":"1090","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.10.075_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jvs.2007.11.033","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)","volume":"47","author":"Krankenberg","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.10.075_bib12","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/CIRCULATIONAHA.113.001849","article-title":"Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial","volume":"127","author":"Rastan","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.10.075_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1526602814564386","article-title":"Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial","volume":"22","author":"Rastan","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.10.075_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.10.075_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"Laird","year":"2012","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.10.075_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1526602819826591","article-title":"Self-expanding nitinol stent vs percutaneous transluminal angioplasty in the treatment of femoropopliteal lesions: 3-year data from the SM-01 trial","volume":"26","author":"Iida","year":"2019","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.10.075_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00270-012-0492-z","article-title":"Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study","volume":"36","author":"Chalmers","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2020.10.075_bib18","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2020.10.075_bib19","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"Schillinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.10.075_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX PI randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.10.075_bib21","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.jcin.2018.07.029","article-title":"Clinical randomized trial evaluating novel, microcrystalline, and biocompatible polymer paclitaxel-coated balloon for the treatment of femoropopliteal occlusive disease: the BIOPAC Trial","volume":"11","author":"Buszman","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.10.075_bib22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00270-017-1713-2","article-title":"Angiographic and clinical outcomes after treatment of femoro-popliteal lesions with a novel paclitaxel-matrix-coated balloon catheter","volume":"40","author":"Tepe","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2020.10.075_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00270-018-1940-1","article-title":"Two-year clinical outcomes of the CONSEQUENT trial: can femoropopliteal lesions be treated with sustainable clinical results that are economically sound?","volume":"41","author":"Albrecht","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2020.10.075_bib24","doi-asserted-by":"crossref","first-page":"e1633","DOI":"10.4244\/EIJ-D-19-00292","article-title":"Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial","volume":"15","author":"Teichgr\u00e4ber","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jvs.2020.10.075_bib25","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.10.075_bib26","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"JACC Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2020.10.075_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.10.075_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial","volume":"25","author":"Iida","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.10.075_bib29","first-page":"664","article-title":"Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial","volume":"93","author":"Iida","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.10.075_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN. PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.10.075_bib31","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN. PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.10.075_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2020.10.075_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2020.10.075_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1526602817710770","article-title":"Six-month results from the initial randomized study of the Ranger paclitaxel-coated balloon in the femoropopliteal segment","volume":"24","author":"Bausback","year":"2017","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.10.075_bib35","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jcin.2018.01.276","article-title":"12-month results from the first-in-human randomized study of the ranger paclitaxel-coated balloon for femoropopliteal treatment","volume":"11","author":"Steiner","year":"2018","journal-title":"JACC Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2020.10.075_bib36","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.10.075_bib37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jvs.2007.11.044","article-title":"Surgical implications of early failed endovascular intervention of the superficial femoral artery","volume":"47","author":"Joels","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.10.075_bib38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jvs.2010.09.069","article-title":"Clinical outcomes and implications of failed infrainguinal endovascular stents","volume":"53","author":"Gur","year":"2011","journal-title":"J\u00a0Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420324824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420324824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:32:38Z","timestamp":1760041958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521420324824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0741521420324824"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2020.10.075","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2020.10.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}